Career Enhancement Program

职业提升计划：摘要/摘要 职业提升计划(CEP)的目标是培养训练有素的、杰出的年轻人 致力于胰腺癌早期发现、预防和治疗的转化型研究人员 癌症(PDAC)和结直肠癌(CRC)。理想情况下，这些调查人员最终将有助于减少 这些疾病的发病率和死亡率。CEP将扩展到两个参与方 机构-MD安德森和约翰霍普金斯大学，拓宽了专业知识和指导的范围 为早期职业调查人员提供的机会。强调我们项目的共同性质，CEP 将分别由约翰·霍普金斯大学的伊丽莎白·贾菲博士和MD Anderson的斯科特·科佩茨博士领导。这个 CEP将A)招聘和培训医生和基础科学家，使他们能够成为高技能的翻译 PDAC或CRC B)领域的研究人员提供PDAC或CRC研究的具体知识，这些知识将 提高获奖者开展创新翻译科学的能力，这将直接影响 对这些疾病的了解和治疗；以及3)重新定向已经表现出 在PDAC或CRC研究方面有相当大的科学前景。为实现这一目标，孢子CEP将提供 最多五个奖项，每个奖项每年50,000美元，为期一年，另有竞争选项可续签 去年，资金来自孢子以及MD Anderson和Johns Hopkins的匹配资金。我们将积极进取 招募最有前途的年轻研究人员，制定个性化的发展计划，包括临床和 实验室导师和指导委员会将提供赠款和手稿写作方面的指导， 领导力培训，与PDAC和CRC学者(同时包括关键意见领袖)建立联系 资助全国各地的孢子项目)，完成并出版与PDAC或CRC相关的翻译 高影响力同行评议期刊上的手稿。GI孢子将利用内部和内部的多种程序 在研究所之外物色优秀的年轻调查人员，重点是招聘合格的 妇女和传统上代表人数不足的群体的成员。CEP还将鼓励和支持 获奖者在国家或国际会议上发表演讲。我们CEP的最终成果是培训和 培养最高素质的下一代胃肠道癌症翻译研究科学家。

CAREER ENHANCEMENT PROGRAM: Summary/Abstract The goal of the Career Enhancement Program (CEP) is to develop highly trained, exceptional young investigators dedicated to translational research in the early detection, prevention, and treatment of pancreatic cancer (PDAC) and colorectal cancer (CRC). Ideally, these investigators will ultimately help to reduce the morbidity and mortality from these diseases. The CEP will extend be available across both participating institutions –MD Anderson and Johns Hopkins University, broadening the scope of expertise and mentorship opportunities available to early career investigators. Underscoring the shared nature of our program, the CEP will be led by Drs. Elizabeth Jaffee at Johns Hopkins and Dr, Scott Kopetz at MD Anderson, respectively. The CEP will A) recruit and train physicians and basic scientists to enable them to become highly skilled translational investigators in the field of PDAC or CRC B) provide specific knowledge of research in PDAC or CRC that will enhance the ability of awardees to conduct innovative translational science that will directly impact on the understanding and treatment of these diseases; and 3) re-direct individuals who have already shown considerable scientific promise into PDAC or CRC research. To achieve this goal, the SPORE CEP will provide up to five awards of $50,000 each annually for one year, with a competitive option for renewal for an additional year, funded from the SPORE and matching funds from MD Anderson and Johns Hopkins. We will aggressively recruit the most promising young investigators and institute an individualized development plan with clinical and laboratory mentors and a mentoring committee that will provide coaching in grant and manuscript writing, leadership training, networking with PDAC and CRC scholars (including key opinion leaders in concurrently funded SPORE programs around the country), and completing and publishing translational PDAC or CRC related manuscripts in high impact peer reviewed journals. The GI SPORE will utilize multiple programs inside and outside of the Institute to identify outstanding young investigators with an emphasis placed on recruiting qualified women and members of traditionally underrepresented groups. The CEP will also encourage and support awardee presentations at national or international meetings. The ultimate deliverable of our CEP is to train and cultivate the highest caliber of next generation translational research scientists in GI cancers.